Vascular graft infections:: In vitro and in vivo investigations of a new vascular graft with long-term protection

被引:20
|
作者
Ueberrueck, T
Zippel, R
Tautenhahn, J
Gastinger, I
Lippert, H
Wahlers, T
机构
[1] Univ Jena, Dept Cardiothorac & Vasc Surg, D-07747 Jena, Germany
[2] Carl Thiem Hosp, Dept Surg, D-03048 Cottbus, Germany
[3] Otto Von Guericke Univ, Dept Surg, D-39120 Magdeburg, Germany
[4] Hosp Reisa, Dept Surg, D-01589 Riesa, Germany
关键词
vascular graft; antimicrobial; sustained release;
D O I
10.1002/jbm.b.30265
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
We investigated a polyester vascular prosthesis (PET) coated with elemental silver (SC). Measurement of silver release over a period of 52 weeks by means of inductively coupled plasma atomic emission spectrometry of PET with (PET-G) and without (PET-N) gelatine impregnation revealed a silver release on the first day of 1.2 +/- 0.2 mu g (PET-N) and 1.2 +/- 0.1 mu g (PET-G) (calculated for 1 g of prosthesis); from the 90th day onward, it was between 0.22 +/- 0.14 mu g (PET-N) and 0.18 +/- 0.12 mu g (PET-G) per day. The prostheses were incubated with Staphylococcus aureus (S.a.), Staphylococcus epidermidis (S.e.), or Escherichia coli (E.c.) to investigate in vitro antibacterial efficacy. After 6 h of incubation, no colony-forming units were to be seen for any of the bacterial suspensions for PET with SC (p < 0.001). To investigate in vivo antibacterial efficacy, PET-G rings with and without SC contaminated with S.a., S.e., or E.c. were implanted in 18 albino rabbits and examined 7 days after agar culture for 48 h. The silver coating was associated with a significant reduction in bacterial growth (S.a.,p = 0.001; S.e.,p < 0.005; E.c.,p < 0.001). The silver-coated prosthesis, with and without gelatine impregnation, had a significantly antibacterial effect with continuous release of silver. (c) 2005 Wiley Periodicals, Inc.
引用
收藏
页码:601 / 607
页数:7
相关论文
共 50 条
  • [1] Vascular graft infections
    Hasse, Barbara
    Husmann, Lars
    Zinkernagel, Annelies
    Weber, Rainer
    Lachat, Mario
    Mayer, Dieter
    SWISS MEDICAL WEEKLY, 2013, 143
  • [2] Vascular graft infections
    Leroy, Olivier
    Meybeck, Agnes
    Sarraz-Bournet, Beatrice
    d'Elia, Piervito
    Legout, Laurence
    CURRENT OPINION IN INFECTIOUS DISEASES, 2012, 25 (02) : 154 - 158
  • [3] Vascular Graft Infections
    Young, Michael H.
    Upchurch, Gilbert R., Jr.
    Malani, Preeti N.
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2012, 26 (01) : 41 - +
  • [4] Long-Term Outcomes of the Flixene Vascular Graft Used for Haemodialysis
    He, Bulang
    Taylor, Duxxa
    Ng, Zi Qin
    Samuelson, Shaun
    Nadkarni, Sanjay
    Van Myk, Matt
    Ferguson, John
    Tibballs, Jonathan
    Chan, Doris
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (02)
  • [5] Vascular rejection with tacrolimus and potential long-term graft outcome
    Vanrenterghem, Y
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (7A) : 86S - 87S
  • [6] In vitro and in vivo biodurability of a compliant microporous vascular graft
    Edwards, A
    Carson, RJ
    Szycher, M
    Bowald, S
    JOURNAL OF BIOMATERIALS APPLICATIONS, 1998, 13 (01) : 23 - 45
  • [7] Alloplastic vascular grafts and vascular graft infections
    Taher F.
    Assadian O.
    Falkensammer J.
    Senekowitsch C.
    Assadian A.
    Gefässchirurgie, 2016, 21 (3) : 145 - 150
  • [8] PATHOGENESIS OF VASCULAR GRAFT INFECTIONS
    CHAUDHARY, R
    SIMMONS, RL
    JOURNAL OF VASCULAR SURGERY, 1991, 13 (05) : 755 - 756
  • [9] Vascular graft infections: an update
    Bunt, TJ
    CARDIOVASCULAR SURGERY, 2001, 9 (03): : 225 - 233
  • [10] Vascular Graft Infections An update
    Gharamti, Amal
    Kanafani, Zeina A.
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2018, 32 (04) : 789 - +